scholarly journals Nerve Stimulator Guided Lumbar Plexus and Parasacral Sciatic Nerve Block for above Knee Amputation in a High-Risk Patient: A Case Report

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Cano Penafrancia Catangui
Keyword(s):  
Case Report ◽  
High Risk ◽  
Sciatic Nerve ◽  
Nerve Block ◽  
High Risk Patient ◽  
Sciatic Nerve Block ◽  
Lumbar Plexus ◽  
Risk Patient ◽  
Nerve Stimulator ◽  
Knee Amputation

scholarly journals Ropivacaine 0.25% is as Effective as Bupivacaine 0.25% in Providing Surgical Anaesthesia for Lumbar Plexus and Sciatic Nerve Block in High-Risk Patients: Preliminary Report

2007 ◽  
Vol 35 (4) ◽  
pp. 510-514 ◽  
Author(s):  
A. Kocum ◽  
A. Turkoz ◽  
H. Ulger ◽  
M. Sener ◽  
G. Arslan
Keyword(s):  
High Risk ◽  
Sciatic Nerve ◽  
Nerve Block ◽  
Sciatic Nerve Block ◽  
Lumbar Plexus ◽  
Analgesic Requirement ◽  
Rescue Analgesia ◽  
High Risk Patients ◽  
Significant Difference ◽  
Risk Patients

Ropivacaine is potentially less cardiotoxic and neurotoxic than bupivacaine. The aim of this study was to compare the effectiveness of ropivacaine 0.25% and bupivacaine 0.25% for surgical anaesthesia and postoperative analgesia during lumbar plexus and sciatic nerve block in high-risk patients. We performed combined lumbar plexus and sciatic nerve blockade on 62 consecutive ASA III or IV patients undergoing unilateral hip or femur surgery. The first 30 patients received bupivacaine (Group 1) and the remaining 32 patients received ropivacaine (Group 2). Perioperative management was otherwise similar. The groups were compared for the time of onset of the block, additional analgesics and sedatives required, time from end of surgery to the first analgesic requirement and the need for rescue analgesia. Ninety percent (29/32) of the patients in the ropivacaine group and 86% (26/30) of the patients in the bupivacaine group reached surgical anaesthesia. The time from the end of the surgery to the first analgesic requirement was similar between the two groups (10.3±5.2 hours for ropivacaine, 11.2±4.6 hours for bupivacaine). There was no statistically significant difference between the two groups in any of the measured variables (P>0.05). The results of this preliminary study suggest that ropivacaine 0.25% is as effective as bupivacaine 0.25% when used for blocking lumbar plexus and sciatic nerve in high-risk patients undergoing hip or femur surgery.

Ultrasound-Guided Combined Lumbar Plexus Block and Sciatic Plexus Block in a High Risk Patient With Alterated Response to Nerve Stimulation

2008 ◽  
Vol 33 (Sup 1) ◽  
pp. e119
Author(s):  
R. Ortiz de la Tabla González ◽  
Martínez Á. Navas ◽  
J.L. Laguillo Cadenas ◽  
Vázquez T. Gutierrez ◽  
Echevarría M. Moreno
Keyword(s):  
High Risk ◽  
Nerve Stimulation ◽  
High Risk Patient ◽  
Lumbar Plexus ◽  
Risk Patient ◽  
Ultrasound Guided ◽  
Lumbar Plexus Block ◽  
Plexus Block
Sign in / Sign up

Export Citation Format

Share Document